Matthew P. Young
2018
In 2018, Matthew P. Young earned a total compensation of $3.4M as Executive Vice President and CFO at Jazz Pharmaceuticals, a 2% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $365,000 |
|---|---|
| Option Awards | $1,083,695 |
| Salary | $575,385 |
| Stock Awards | $1,322,297 |
| Other | $9,960 |
| Total | $3,356,337 |
Young received $1.3M in stock awards, accounting for 39% of the total pay in 2018.
Young also received $365K in non-equity incentive plan, $1.1M in option awards, $575.4K in salary and $10K in other compensation.
Rankings
In 2018, Matthew P. Young's compensation ranked 3,412th out of 14,244 executives tracked by ExecPay. In other words, Young earned more than 76.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,412 out of 14,244 | 76th |
Division Manufacturing | 1,262 out of 5,759 | 78th |
Major group Chemicals And Allied Products | 442 out of 2,122 | 79th |
Industry group Drugs | 364 out of 1,811 | 80th |
Industry Pharmaceutical Preparations | 279 out of 1,385 | 80th |
Pay ratio
| Matthew P. Young's Pay | $3,356,337 |
|---|---|
| Median Employee's Pay | $216,797 |
| Pay Ratio | 15to 1 |
In 2018, the annual total compensation of Matthew P. Young was $3,356,337.
The annual total compensation of the median employee at Jazz Pharmaceuticals was $216,797.
The ratio of Matthew P. Young's pay to the pay of median employee was therefore 15 to one.
Source: SEC filing on June 14, 2019.
Young's colleagues
We found four more compensation records of executives who worked with Matthew P. Young at Jazz Pharmaceuticals in 2018.